73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Why start mammograms at 40? Doctor explains new advice

Why start mammograms at 40? Doctor explains new advice

by Samantha Laine Perfas,Harvard UniversityCredit: Unsplash/CC0 Public DomainWomen should start getting regular mammograms at the age of 40, according toa new recommendationbeing dra

Why start mammograms at 40? Doctor explains new advice

by Samantha Laine Perfas,Harvard UniversityCredit: Unsplash/CC0 Public DomainWomen should start getting regular mammograms at the age of 40, according toa new recommendationbeing dra
Liver cancer: Risk factors and prevention

Liver cancer: Risk factors and prevention

by Laurel Kelly,Mayo ClinicCredit: Pixabay/CC0 Public DomainOctober is Liver Cancer Awareness Month, which makes this a good time to learn more about risk factors for liver cancer and what you c

Liver cancer: Risk factors and prevention

by Laurel Kelly,Mayo ClinicCredit: Pixabay/CC0 Public DomainOctober is Liver Cancer Awareness Month, which makes this a good time to learn more about risk factors for liver cancer and what you c
Divarasib Displays Early-Phase Activity in KRAS G12C–Mutant Solid Tumors

Divarasib Displays Early-Phase Activity in KRAS G12C–Mutant Solid Tumors

September 5, 2023Kyle DohertyTreatment with the KRAS G12C inhibitor divarasib (formerly GDC-6036)led to durable responses with a tolerable safety profile in patients with a variety of solid tumo

Divarasib Displays Early-Phase Activity in KRAS G12C–Mutant Solid Tumors

September 5, 2023Kyle DohertyTreatment with the KRAS G12C inhibitor divarasib (formerly GDC-6036)led to durable responses with a tolerable safety profile in patients with a variety of solid tumo
Single set of criteria to assess progression in glioma aims to speed discovery of new medicines

Single set of criteria to assess progression in glioma aims to speed discovery of new medicines

byDana-Farber Cancer InstituteInfant high-grade glioma. Credit: David Ellison, St. Jude Children’s Research HospitalIn order to accurately assess the efficacy of novel therapies for brain tumors

Single set of criteria to assess progression in glioma aims to speed discovery of new medicines

byDana-Farber Cancer InstituteInfant high-grade glioma. Credit: David Ellison, St. Jude Children’s Research HospitalIn order to accurately assess the efficacy of novel therapies for brain tumors
Everything You Need to Know About Blood Sugar Tests

Everything You Need to Know About Blood Sugar Tests

Everything You Need to Know About Blood Sugar TestsByRachael Zimlich, BSN, RNPublished on January 10, 2022Medically reviewed byDo-Eun Lee, MDDiabetes is a chronic condition tha

Everything You Need to Know About Blood Sugar Tests

Everything You Need to Know About Blood Sugar TestsByRachael Zimlich, BSN, RNPublished on January 10, 2022Medically reviewed byDo-Eun Lee, MDDiabetes is a chronic condition tha
Trial supports radiotherapy and cisplatin remaining as the standard of care for p16+ oropharyngeal cancer

Trial supports radiotherapy and cisplatin remaining as the standard of care for p16+ oropharyngeal cancer

by NRG OncologyCredit: Pixabay/CC0 Public DomainThe NRG Oncology NRG-HN005 phase II/III clinical trial has not met the non-inferiority criteria to proceed to the phase III portion of the study. The ph

Trial supports radiotherapy and cisplatin remaining as the standard of care for p16+ oropharyngeal cancer

by NRG OncologyCredit: Pixabay/CC0 Public DomainThe NRG Oncology NRG-HN005 phase II/III clinical trial has not met the non-inferiority criteria to proceed to the phase III portion of the study. The ph
Immunotherapy for Cancer: What Are My Options?

Immunotherapy for Cancer: What Are My Options?

ByJennifer WelshPublished on September 06, 2023Medically reviewed byDoru Paul, MDImmunotherapy is a relatively new approach to cancer treatment. It improves the body's immu

Immunotherapy for Cancer: What Are My Options?

ByJennifer WelshPublished on September 06, 2023Medically reviewed byDoru Paul, MDImmunotherapy is a relatively new approach to cancer treatment. It improves the body's immu
Novel risk score for cardiovascular complications after bone marrow transplant

Novel risk score for cardiovascular complications after bone marrow transplant

by Noah Fromson,University of Michigan3D Model of the heart by Dr. Matthew Bramlet. Credit: NIHFor thousands of Americans each year, a bone marrow transplant has the potential to cure diseases s

Novel risk score for cardiovascular complications after bone marrow transplant

by Noah Fromson,University of Michigan3D Model of the heart by Dr. Matthew Bramlet. Credit: NIHFor thousands of Americans each year, a bone marrow transplant has the potential to cure diseases s
Study finds carcinogen exposure makes cancer cells more susceptible to immune attack

Study finds carcinogen exposure makes cancer cells more susceptible to immune attack

by Liz Murphy,Massachusetts General HospitalCarcinogen-exposed cancer cells transform that nature of tumor-infiltrating macrophages from immunosuppressive (left) to immune activating agents (rig

Study finds carcinogen exposure makes cancer cells more susceptible to immune attack

by Liz Murphy,Massachusetts General HospitalCarcinogen-exposed cancer cells transform that nature of tumor-infiltrating macrophages from immunosuppressive (left) to immune activating agents (rig
New insight into BRCA2 gene mutations and cancer risk

New insight into BRCA2 gene mutations and cancer risk

A recent study from researchers at the University of California examines the BRCA2 gene, which plays a crucial role in repairing damaged DNA, and possible links with increased risk of breast and ovari

New insight into BRCA2 gene mutations and cancer risk

A recent study from researchers at the University of California examines the BRCA2 gene, which plays a crucial role in repairing damaged DNA, and possible links with increased risk of breast and ovari
KIT Inhibitors Lead to Shift in Treatment of Systemic Mastocytosis

KIT Inhibitors Lead to Shift in Treatment of Systemic Mastocytosis

September 26, 2023Pankit Vachhani, MD Prithviraj Bose, MDThe hematologic neoplasm systemic mastocytosis is marked by the clonal proliferation of mast cells in the skin, bone marrow, gastrointestinal t

KIT Inhibitors Lead to Shift in Treatment of Systemic Mastocytosis

September 26, 2023Pankit Vachhani, MD Prithviraj Bose, MDThe hematologic neoplasm systemic mastocytosis is marked by the clonal proliferation of mast cells in the skin, bone marrow, gastrointestinal t
Why does a leukemic mutation not always lead to leukemia? A new clue from a mouse study

Why does a leukemic mutation not always lead to leukemia? A new clue from a mouse study

byKeck School of Medicine of USCCredit: Pixabay/CC0 Public DomainWhy do some people with a genetic mutation associated with leukemia remain healthy, while others with the same mutation develop t

Why does a leukemic mutation not always lead to leukemia? A new clue from a mouse study

byKeck School of Medicine of USCCredit: Pixabay/CC0 Public DomainWhy do some people with a genetic mutation associated with leukemia remain healthy, while others with the same mutation develop t